2024
Evaluation of the Contribution of Clinical Parameters for the Diagnosis of Idiopathic Pulmonary Fibrosis by an International Panel of Clinicians
Abecassis C, Pastre J, Hajari Case A, Antin-Ozerkis D, Shifren A, Libre E, Picone C, Johri S, Hindre R, Benattia A, Riviere F, Wemeau L, Ouaknine J, Taverne J, Hamdan A, Ben Dhiab R, Chung J, Dubocage A, Maillard A, King C, Nathan S. Evaluation of the Contribution of Clinical Parameters for the Diagnosis of Idiopathic Pulmonary Fibrosis by an International Panel of Clinicians. 2024, a1766-a1766. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1766.Peer-Reviewed Original Research
2001
Germline Mutations in BRCA1 and BRCA2 in Breast-Ovarian Families From a Breast Cancer Risk Evaluation Clinic
Martin A, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL. Germline Mutations in BRCA1 and BRCA2 in Breast-Ovarian Families From a Breast Cancer Risk Evaluation Clinic. Journal Of Clinical Oncology 2001, 19: 2247-2253. PMID: 11304778, DOI: 10.1200/jco.2001.19.8.2247.Peer-Reviewed Original ResearchConceptsOvarian cancerEvaluation clinicGermline mutationsStudy groupLow-penetrance susceptibility genesBreast Cancer Linkage ConsortiumOvarian cancer familiesBreast cancer diagnosisYounger average ageClinical parametersBreast cancerAverage ageMutation statusHereditary breastMultivariate analysisRegion of BRCA1CancerCancer familiesBreastClinicCancer diagnosisProportion of familiesBRCA2Strongest predictorDirect sequencing